271 related articles for article (PubMed ID: 15693035)
1. No evidence for germ-line transmission following prenatal and early postnatal AAV-mediated gene delivery.
Jakob M; Mühle C; Park J; Weiss S; Waddington S; Schneider H
J Gene Med; 2005 May; 7(5):630-7. PubMed ID: 15693035
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO
Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942
[TBL] [Abstract][Full Text] [Related]
3. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
4. No evidence of germ-line transmission by adenovirus-mediated gene transfer to mouse testes.
Kojima Y; Hayashi Y; Kurokawa S; Mizuno K; Sasaki S; Kohri K
Fertil Steril; 2008 May; 89(5 Suppl):1448-54. PubMed ID: 17624347
[TBL] [Abstract][Full Text] [Related]
5. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
6. Utility of intraperitoneal administration as a route of AAV serotype 5 vector-mediated neonatal gene transfer.
Ogura T; Mizukami H; Mimuro J; Madoiwa S; Okada T; Matsushita T; Urabe M; Kume A; Hamada H; Yoshikawa H; Sakata Y; Ozawa K
J Gene Med; 2006 Aug; 8(8):990-7. PubMed ID: 16685745
[TBL] [Abstract][Full Text] [Related]
7. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.
Kay MA; Manno CS; Ragni MV; Larson PJ; Couto LB; McClelland A; Glader B; Chew AJ; Tai SJ; Herzog RW; Arruda V; Johnson F; Scallan C; Skarsgard E; Flake AW; High KA
Nat Genet; 2000 Mar; 24(3):257-61. PubMed ID: 10700178
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer to the gastrointestinal tract after peroral administration of recombinant adeno-associated virus type 2 vectors.
Shao G; Greathouse K; Huang Q; Wang CM; Sferra TJ
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):168-79. PubMed ID: 16877980
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C
J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068
[TBL] [Abstract][Full Text] [Related]
10. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.
Mitchell M; Jerebtsova M; Batshaw ML; Newman K; Ye X
Gene Ther; 2000 Dec; 7(23):1986-92. PubMed ID: 11175309
[TBL] [Abstract][Full Text] [Related]
11. Successful expression of beta-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein.
Themis M; Schneider H; Kiserud T; Cook T; Adebakin S; Jezzard S; Forbes S; Hanson M; Pavirani A; Rodeck C; Coutelle C
Gene Ther; 1999 Jul; 6(7):1239-48. PubMed ID: 10455432
[TBL] [Abstract][Full Text] [Related]
12. Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.
Couto LB
Semin Thromb Hemost; 2004 Apr; 30(2):161-71. PubMed ID: 15118928
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of a low dose of intravenously administered AAV-2, 10, and 11 vectors to cynomolgus monkeys.
Mori S; Takeuchi T; Enomoto Y; Kondo K; Sato K; Ono F; Iwata N; Sata T; Kanda T
Jpn J Infect Dis; 2006 Oct; 59(5):285-93. PubMed ID: 17060693
[TBL] [Abstract][Full Text] [Related]
14. Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males.
Arruda VR; Fields PA; Milner R; Wainwright L; De Miguel MP; Donovan PJ; Herzog RW; Nichols TC; Biegel JA; Razavi M; Dake M; Huff D; Flake AW; Couto L; Kay MA; High KA
Mol Ther; 2001 Dec; 4(6):586-92. PubMed ID: 11735343
[TBL] [Abstract][Full Text] [Related]
15. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
16. Effects of adenovirus mediated gene transfer to mouse testis in vivo on spermatogenesis and next generation.
Kojima Y; Sasaki S; Umemoto Y; Hashimoto Y; Hayashi Y; Kohri K
J Urol; 2003 Nov; 170(5):2109-14. PubMed ID: 14532865
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
18. Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer.
Ding Z; Georgiev P; Thöny B
Gene Ther; 2006 Apr; 13(7):587-93. PubMed ID: 16319947
[TBL] [Abstract][Full Text] [Related]
19. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
20. AAV vectors for hemophilia B gene therapy.
Chao H; Walsh CE
Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
